[{"NetIncomeLossConverted_1_FY_USD":-47376000.0,"NetIncomeLossConverted_4_FY_USD":-157292000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-82793000.0,"CommonStockSharesOutstanding_0_FY_shares":48678540.0,"StockholdersEquity_0_FY_USD":1109898000.0,"EarningsPerShareBasic_1_FY_USD":-1.02,"EarningsPerShareBasic_4_FY_USD":-3.85,"RevenuesConverted_4_FY_USD":25000000.0,"Assets_0_FY_USD":1136713000.0,"CommonStockSharesConverted_0_FY_shares":48678540.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210301"}]